|The molecular taxonomy of primary prostate cancer|
A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ...
Cell 163 (4), 1011-1025, 2015
|Risk of prostate cancer–specific mortality following biochemical recurrence after radical prostatectomy|
SJ Freedland, EB Humphreys, LA Mangold, M Eisenberger, FJ Dorey, ...
Jama 294 (4), 433-439, 2005
|Early detection of prostate cancer: AUA Guideline|
HB Carter, PC Albertsen, MJ Barry, R Etzioni, SJ Freedland, KL Greene, ...
The Journal of urology 190 (2), 419-426, 2013
|Autonomic nerve development contributes to prostate cancer progression|
C Magnon, SJ Hall, J Lin, X Xue, L Gerber, SJ Freedland, PS Frenette
Science 341 (6142), 1236361, 2013
|Prostate cancer–specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy|
BJ Trock, M Han, SJ Freedland, EB Humphreys, TL DeWeese, AW Partin, ...
Jama 299 (23), 2760-2769, 2008
|Active surveillance for prostate cancer: a systematic review of the literature|
MA Dall’Era, PC Albertsen, C Bangma, PR Carroll, HB Carter, ...
European urology 62 (6), 976-983, 2012
|Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part I: risk stratification, shared decision making, and care options|
MG Sanda, JA Cadeddu, E Kirkby, RC Chen, T Crispino, J Fontanarosa, ...
The Journal of urology 199 (3), 683-690, 2018
|Obesity and prostate cancer: weighing the evidence|
EH Allott, EM Masko, SJ Freedland
European urology 63 (5), 800-809, 2013
|Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer|
NL Keating, AJ O'Malley, SJ Freedland, MR Smith
Journal of the National Cancer Institute 102 (1), 39-46, 2010
|Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital …|
SJ Freedland, WJ Aronson, CJ Kane, JC Presti Jr, CL Amling, D Elashoff, ...
Journal of Clinical Oncology 22 (3), 446-453, 2004
|Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort|
C Rodriguez, SJ Freedland, A Deka, EJ Jacobs, ML McCullough, ...
Cancer Epidemiology and Prevention Biomarkers 16 (1), 63-69, 2007
|Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer|
LL Banez, RJ Hamilton, AW Partin, RT Vollmer, L Sun, C Rodriguez, ...
Jama 298 (19), 2275-2280, 2007
|The correlation between metabolic syndrome and prostatic diseases|
C De Nunzio, W Aronson, SJ Freedland, E Giovannucci, JK Parsons
European urology 61 (3), 560-570, 2012
|The contemporary concept of significant versus insignificant prostate cancer|
G Ploussard, JI Epstein, R Montironi, PR Carroll, M Wirth, MO Grimm, ...
European urology 60 (2), 291-303, 2011
|Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy|
SJ Freedland, ME Sutter, F Dorey, WJ Aronson
Urology 61 (2), 365-369, 2003
|Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction|
LW Jones, ND Eves, M Haykowsky, SJ Freedland, JR Mackey
The lancet oncology 10 (6), 598-605, 2009
|Obesity and prostate cancer: epidemiology and clinical implications|
WC Buschemeyer III, SJ Freedland
European urology 52 (2), 331-343, 2007
|Update on systemic prostate cancer therapies: management of metastatic castration-resistant prostate cancer in the era of precision oncology|
P Nuhn, JS De Bono, K Fizazi, SJ Freedland, M Grilli, PW Kantoff, ...
European urology 75 (1), 88-99, 2019
|Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care|
O Ukimura, JA Coleman, A De La Taille, M Emberton, JI Epstein, ...
European urology 63 (2), 214-230, 2013
|Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study|
SJ Freedland, WB Isaacs, EA Platz, MK Terris, WJ Aronson, CL Amling, ...
Journal of clinical oncology 23 (30), 7546-7554, 2005